Study on the relationship between genes and disease severity, disease burden and effectiveness of disease modifying medication in Dutch patients with Multiple Sclerosis

Completed

• Conditions: 10012303; demyelinating disease; multiple sclerosis; 10003816

• Registration Number: NL-OMON45439
• Lead Sponsor: Drug Target ID, Ltd.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 600

Inclusion Criteria

600 Dutch patients with MS from six MS centres. We estimate that approximately 100 patients per centre will participate in the study, which is a feasible number of patients according to the neurologists of the respective centres.;In order to be eligible to participate in this study, subjects must meet all of the following criteria:
- diagnosed with MS for at least one year
- able and willing to participate in the study
- Dutch and from caucasian origin
- between 20 and 60 years of age;In addition, we are aiming for the gender distribution of our subjects to reflect the epidemiological findings for MS, i.e. approximately 35 % male and 65 % female subjects.

Exclusion Criteria

Not applicable.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified